Objective: Impaired incretin response represents an early and uniform defect in type 2 diabetes but the contributions of genes and the environment are poorly characterized.
The insulinotropic response to intraluminal nutrients is mediated through secretion of gut incretins, mainly Glucagon-like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Peptide (GIP). In healthy individuals, this incretin effect accounts for up to 70% of insulin secretion in oral glucose tolerance test (OGTT) (1) . In their classic study, Nauck et al. demonstrated that compromised incretin effect is a central pathological feature of type 2 diabetes (2).
The inherent nature of the incretin defect in type 2 diabetes has raised speculations whether altered secretion or action of incretins represents a primary, genetically determined defect predisposing to diabetes. Genetic factors are difficult to isolate in demanding metabolic studies, and thus the genetic influence on the incretin response remains poorly characterized. Although several polymorphisms in the GIP receptor have been associated with both obesity and glycemia (3, 4), genetic loci predisposing to type 2 diabetes identified so far do not directly involve GLP-1 or GIP genes (5, 6 ).
Besides GLP-1, intestinal L-cells secrete Peptide YY (PYY), an anorexigenic hormone, in response to nutrient stimuli. Polymorphisms in the PYY gene may contribute to obesity and diabetes risk (7, 8) . Therefore, it is relevant to study whether incretin responses to oral nutrients impaired in obesity are accounted for by genetic variation or due to acquired factors.
Monozygotic (MZ) and dizygotic (DZ) twins offer a study design to estimate the relative contribution of genes and environment to various traits. Closer resemblance of MZ twins as compared to DZ twins suggests the importance of genetic factors to the trait under study.
Phenotypically discordant MZ twins are of special interest as the two extremes of the phenotype do not differ in their genomic sequence but all of the variability in the phenotype is accounted for by variations in the environmental factors or gene-environment interaction (9) .
The aims of our study were to investigate the heritability of GLP-1, insulin and glucose response after an OGTT in young adult twin pairs. In addition, GLP-1 and GIP responses after an OGTT and GLP-1 and PYY after a mixed meal were studied in more detail in MZ twin pairs who are Page 4 of 30 Diabetes Care discordant only for weight or discordant for weight, liver fat and insulin sensitivity i.e. present a pattern of metabolically healthy or unhealthy obesity.
Research Design and Methods

Subjects
The present study consists of 110 twin pairs, 35 MZ (17 male and 18 female) and 75 DZ (43 male and 32 female) pairs, aged 22.8-33.1 years, identified from Finn Twin16 and Finn Twin12 cohorts (n=5,417 families) (10, 11) . Twenty-three MZ twins have detailed measurements of adiposity, and their initial data has been published previously (12 HOMA-IR (14) and Matsuda index (15) were calculated using glucose and insulin measurements from the OGTT measurements. GLP-1, GIP and PYY area under the curves (AUC) were calculated using the trapezoid rule.
Analytical measures
Plasma and serum insulin were measured as described (12) . GIP and GLP-1 concentrations in plasma were measured after extraction of plasma with 70 % ethanol (vol/vol, final concentration).
For the GIP radioimmunoassay (16) we used the C-terminally directed antiserum code #867, which was raised against a synthetic peptide corresponding to the C-terminus of human GIP. It does not crossreact with the so-called GIP 8000, whose chemical nature and relationship to GIP secretion is uncertain. It reacts fully with the primary metabolite, GIP 3-42. Human GIP and 125-I human GIP (70 MBq/nmol) were used for standards and tracer. The plasma concentrations of GLP-1 were measured (17) against standards of synthetic GLP-1 7-36amide using antiserum code #89390, which is specific for the amidated C-terminus of GLP-1 and therefore does not react with GLP-1-containing peptides from the pancreas. The results of the assay accurately reflect the rate of secretion of GLP-1 because the assay measures the sum of intact GLP-1 and the primary metabolite, GLP-1 9-36amide, into which GLP-1 is rapidly converted. For both assays sensitivity was below 1 pmol/l, intra assay CV below 6 % at 20 pmol/l, and recovery of standard, added to plasma before extraction, about 100 % when corrected for losses inherent in the plasma extraction procedure.
Statistical analyses
Statistical Heritability is a population-specific characteristic that has no interpretation on the level of the individual or family. One can fit models based on the different combinations of these parameters:
ADE, ACE, AE, and CE, but effects due to dominance and shared environmental effects cannot be simultaneously modeled with data limited to that from twins reared together. Also, DE models, in which the effects of D and E are estimated but the additive genetic effects are fixed to zero were not fitted because such models are biologically implausible (19) . The ACE and ADE model were compared with one another using the Akaike´s information criterion (AIC) (20) . The model with the lower AIC was used as a starting point of the modeling, from which the significance of variance components was tested by removing them sequentially in nested submodels. Model fit was assessed using the -2 log likelihood. Submodels were compared with the full models by use of hierarchical χ2 tests. The best model fit was evaluated according to the principle of parsimony, in which models with fewer parameters were considered preferable if the removal did not result in a significant degradation of model fit. The goodness-of-fit of the submodels was also evaluated by the AIC.
Classical twin models assume that MZ and DZ pairs share common environmental factors to the same extent, no interaction between genes and no gene-environment interactions (20) . Saturated models were used to test the basic assumptions of twin modeling (equal means and variances for twin1 and twin2 and for MZ and DZ pairs). No age effect was seen in the saturated models. For the estimation of variance components and ICCs, log-transformed and sex adjusted values were used.
Results
Heritability of GLP-1 and insulin sensitivity measures
The means (SE), ICCs and heritability estimates of the best fitting models of GLP-1 and insulin sensitivity measures are given in Table 1 implausible, AE models were chosen as the best fitting model. The heritability of variables for insulin sensitivity/resistance ranged from 52-60%, while that of GLP-1-AUC was 67%. The remaining variance was explained by unique environmental factors. In contrast, for fasting GLP-1, the genetic contribution was not significant, and the variance in fasting GLP-1 was explained solely by common (58%, 95% CI: 44-69%) and unique (42%, 95% CI: 31-56%) environmental factors (Table 1) .
MZ and DZ pairs discordant for obesity
Adiposity and metabolic measures for MZ and DZ twin pairs are summarized in Table 2 . In the MZ obesity-discordant pairs, the average intra-pair difference (∆) of BMI was 5. . The MZ obesity-discordant pairs could be further divided to liver fat discordant orconcordant groups, based on a cut off of 2.5%, the mean ∆liver fat within all MZ discordant pairs.
In group 1, all obese and non-obese co-twins had low liver fat contents (range 0.3-0.8%, mean ∆liver fat 0.04%), whereas in group 2 the liver fat in the obese (range 3.8-9.4%) was on average 4.9
percentage points higher than in the non-obese co-twins (range 0.4-3.5%). Group 1 (∆5.8 kg/m 2 ) and group 2 (∆5.4 kg/m 2 ) had equally large BMI differences. The obese twins in group 2 had significantly higher liver fat content (p=0.0012) and intra-abdominal fat volume (p=0.037) than obese twins in group 1, but the other adiposity measures did not differ. Lean co-twins between the groups did not differ on any adiposity measures or sex.
The MZ obesity-discordant groups 1 and 2 differed significantly for metabolic health. While the obese twins in the group 1did not differ from their lean co-twins for HOMA in fasting (p=0.50) or
Matsuda-index during the OGTT (p=0.69), the obese twins in group 2 had significantly higher HOMA (p=0.018) and lower Matsuda (0.028) than the lean twin pair members. In the DZ pairs, liver fat was not measured and groupings for liver fat could not be done. In the whole DZ obesitydiscordant group, HOMA (p=0.0022) and Matsuda indexes (p= 0.0023) revealed significantly poorer insulin sensitivity in the obese as compared with the lean co-twins. Concordant MZ and DZ twin pairs had statistically significant adiposity differences between leaner and heavier co-twins but metabolically the co-twins resembled each other within pairs.
Effects of acquired obesity on glucose, insulin and incretin responses
In the OGTT, glucose, insulin and GLP-1 responses did not differ within group 1 obesity-discordant MZ pairs ( Figure 1 , Table 2 ), suggesting that obese individuals who remain insulin sensitive do not have altered GLP-1 secretion. In contrast, within group 2 obesity-discordant MZ pairs, GLP-1 was blunted at 60 min in every obese co-twin as compared with their leaner counterparts (p=0.022).
Both AUC glucose (p=0.028) and AUC insulin (p=0.028) were significantly higher in the group 2 obese than non-obese co-twins. Similar tendencies were observed for the meal test although they were significant only for the AUC insulin, which was increased in the group 2 obese as compared with the non-obese co-twins (p=0.047).
In the DZ obesity-discordant pairs, the AUC GLP-1 during the OGTT was significantly lower in the obese than in the non-obese co-twins (p=0.029). The obese co-twins also had higher glucose and insulin values at 0 and 120 minutes (p<0.05).
GIP was measured in MZ pairs during the OGTT. Neither the group 1 nor group 2 obesitydiscordant pairs revealed significant differences between the co-twins. However, it is of note that the GIP response was not lower (rather the opposite) in the insulin resistant group 2 obese twins ( Figure 1 , Table 2 ).
In MZ and DZ concordant pairs, all incretin, glucose and insulin measures were the same for all cotwins within pairs (Figure 1 and 2 , Table 2 ).
Effects of obesity on the relative responses of incretins to glucose and insulin
The ratios of GLP-1-or GIP-AUC to glucose-and insulin-AUC are shown in 
PYY3-36
PYY3-36 was measured during the meal test in MZ twins. It did not differ between the group 1 and group 2 obesity-discordant groups (data not shown). PYY3-36 AUC in the leaner vs. heavier cotwins was 108.9±7.7 vs. 119.6±10.8 pg/ml (p=0.18) in the discordant and 104.4±15.8 vs.
105.3±25.4 pg/ml (p=0.71) in the concordant twin pairs.
Discussion
We studied the contribution of genes and environment to incretin response after an OGTT in a population of healthy MZ and DZ twin pairs using a classic twin design. Based on measurements of the major incretin, GLP-1 after an OGTT, we estimate the heritability of GLP-1 response to be 67 %. Furthermore, we demonstrate in a unique sample of weight and liver fat discordant twin pairs that defective incretin response to OGTT or mixed meal associates with features of high liver fat and insulin resistance.
Because incretin defect in type 2 diabetes appears early and apparently uniformly in type 2 diabetes, the question under study has long been if altered secretion of incretins represents a primary genetic defect (21) . To our knowledge, our study is the first one to address the question if incretin defect is genetic or associated with acquired obesity. We found that the response of GLP-1 after OGTT is highly correlated within MZ and to a lesser extent within DZ twin pairs, and that genetic factors An acquired "healthy" pattern of obesity determined by low liver fat and/or normal HOMA and Matsuda indexes was not associated with an altered incretin response. Further, the PYY-36 and GIP responses to oral nutrients were not altered in acquired obesity per se. Previous data on healthy subjects demonstrate that the incretin response is independent of prevailing glucose concentration and that GLP-1 response is a rather reproducible among individuals (23) . In line with our results, no incretin defect were demonstrated in the first degree relatives of patients with type 2 diabetes as compared to healthy controls with comparable insulin sensitivity (24) or in women with a history of gestational diabetes (25) . These studies support our findings that obese co-twins with preserved insulin sensitivity had normal GLP-1, GIP, insulin and glucose concentrations after OGTT and meal test.
We could identify an extremely informative subset of MZ twin pairs who are discordant for obesity, liver fat and insulin resistance, i.e. each pair includes a metabolically healthy lean vs. an unhealthy obese twin with identical genotype. The heavier, more insulin resistant co-twin group with higher liver fat showed blunted GLP-1 response to both oral challenges. That finding was confirmed among weight discordant DZ twin pairs, among whom the heavier co-twin group also displayed blunted GLP-1 and higher insulin response to OGTT as compared to leaner co-twin group. It must be noted that the DZ weight discordant twin pairs did not undergo liver fat measurement but as a group they clearly represent the unhealthy obesity pattern based on significantly higher HOMA-IR and lower Matsuda indeces. Most of the previous data also support our view that impaired incretin response develops concomitantly with the features of insulin resistance rather than represents a primary genetic trait that drives the progress to type 2 diabetes (1, 26, 27) . In the present study, a clustering of metabolic risk factors with increased liver fat an insulin resistance was required on top of simple obesity for impaired incretin response to develop. However, whether the metabolically unhealthy obesity pattern is acquired or represents interactions between susceptibility genes and environment, remains to be determined.
Single nucleotide polymorphism (SNPs) affecting diabetes risk that are associated with incretin secretion or action are surprisingly few and do not reveal if incretin defect precedes diabetes or requires insulin resistance to develop. So far, identified genes include TCF7L2, GIP receptor, WSF1 and KCNQ1 that mostly regulate the incretin effect on islet cells rather than concentrations of GLP-1 and GIP (3, 4, 6). Carriers of the T allele of TCLF7 variant rs7903146 demonstrate 30% loss of the incretin effect suggesting impaired β-cell capacity to respond to incretin stimulus (28) .
Also GIP receptor and WSF1 affect the pancreatic incretin-dependent insulin signaling pathways.
Only KCNQ1 SNPs theoretically may impair ileal incretin secretion (6) . Recently, Smushkin et al.
reported in healthy individuals that TCF7L2, WFS1 and KCNQ1 genotypes had no effect on GLP-1 concentrations after an OGTT, or on β-cell responsiveness to hyperglycemic clamp and GLP-1 infusion (29) . Based on these findings we assume that the β-cells of the healthy subjects in our study respond normally to GLP-1. Furthermore, we found that the heavier MZ weight discordant twins with low liver fat were able to even increase their GLP-1 secretion during OGTT and mixed meal at 30 minutes with simultaneous increase in insulin secretion. This resulted in maintenance of identical glucose levels as observed in their leaner twin pairs. Our data suggest that the incretin response to oral nutrients is well preserved and may even compensate for the increased insulin requirements in metabolically healthy obese subjects. Instead, the heavier MZ weight discordant twins with high liver fat showed slightly decreased GLP-1 levels, clearly elevated insulin and glucose levels during the OGTT and mixed meal. The data suggest that the enhanced insulin response in the metabolically unhealthy heavier MZ is not accounted for by GLP-1 secretion but presumably by direct effects of elevated glucose concentrations.
A severely reduced incretin response is a uniform finding in type 2 diabetes, in which the β-cell insulin secretion due to incretins may be reduced to < 20% from that of healthy subjects (2) . The data in subjects with diabetes on GLP-1 and GIP plasma levels are conflicting with studies reporting especially reduced, unaltered and increased GIP concentrations after OGTT (2, (30) (31) (32) (33) . It must be noted that these studies include subjects from mixed populations with variable genetic background and duration of full-blown diabetes in which both reduced secretion and impaired action of incretins have been suggested as the culprit. Our young and healthy study population, on the other hand, does not have diabetes, originates from a genetically homogeneous Finnish population, and is perfectly matched for genes between the obese and non-obese subjects.
Therefore, one can assume that the differences in GLP-1 and GIP responses relative to insulin and glucose responses detected between weight and liver fat discordant MZ twin pairs are representing the true impairment in GLP-1 metabolism and relatively more preserved GIP response elicited by the phenotype. Because of our study design, we are not able to estimate if insulinotropic action of GIP on β-cell is impaired or not in the metabolically unhealthy pattern of obesity.
Our finding that leaner and heavier co-twins of obesity-discordant MZ pairs demonstrate a similar AUC for PYY levels is in contradiction with reports of decreased PYY secretion after meal in obesity in individuals (34, 35) . This finding suggests that common genetic or environmental factors may underlie obesity and PYY response to oral nutrients. Also, our subjects were young with a very homogeneous background and only a moderate degree of obesity which may also account for discrepancies between findings.
Young adult obesity-discordant MZ twins with no major confounding factors such as medications and other diseases are extremely rare, and despite screening of ten yearly cohorts with well over 5,000 twin pairs, the final sample size was quite small and therefore potentially underpowered.
However, this selection procedure provided a highly informative sample for studying the association between aquired obesity and incretin reponse. Regarding the representativeness of the twin model estimates from this selected sample, it has been shown with simulated twin data that the bias resulting from the extreme concordant and discordant design is minimal (36) . Other limitations include lack of measurement of glucagon that has been linked to impaired incretin response and not performing laborious clamp-studies which would have measured directly insulin sensitivity and the β-cell incretin responses (37) . However, the use of HOMA and Matsuda indices has been previously well validated in healthy subjects (38) . *The best fitting model, also highlighted in bold. 95% Confidence intervals are given in parentheses.
AUC, area under the curve; LL, log likelihood; AIC, Akaike´s information criterion; ∆, Difference between the full model and submodel.
Note: DE models, in which the effects of D and E are estimated but the additive genetic effects are fixed to zero were not fitted because such models are biologically implausible (Neale MC, Cardon LR, Methodology for genetic studies of twins and families. Dordrecht, Netherlands: Kluwer, Academic, 1992).
